See every side of every news story
Published loading...Updated

ImmixBio Reports No Neurotoxicity in CAR-T Therapy for AL Amyloidosis

Summary by stocktitan.net
New clinical data reveals breakthrough safety profile for NXC-201 CAR-T therapy in AL Amyloidosis. Zero neurotoxicity could enable broader applications. See full results.

7 Articles

All
Left
Center
1
Right

In this week, Health Minister Alexandre Padilla said Brazil intends to develop CAR-T therapy against cancer in national territory, through a partnership with the countries of the Brics. Treatment, which uses the cells of the patient's own to attack the tumor, is considered a great step forward, and has proved promising to treat cancer that affects blood. However, the value of CAR-T therapy is very high, and can cost R$3 million per patient. One …

·Brazil
Read Full Article

Although cell and gene therapies are not yet standard treatments in everyday clinical practice, they are becoming increasingly important for diseases that are currently untreatable or difficult to treat. One special form of treatment is CAR-T cell therapy, which uses immune cells...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Newstrail.com broke the news in on Thursday, July 10, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.